首页>
外国专利>
PULMONARY DELIVERY OF RIBAVIRIN OR LEVOVIRINamp;trade; FOR SYSTEMIC AND QUASI-SYSTEMIC TREATMENT OF DISEASE
PULMONARY DELIVERY OF RIBAVIRIN OR LEVOVIRINamp;trade; FOR SYSTEMIC AND QUASI-SYSTEMIC TREATMENT OF DISEASE
展开▼
机译：利巴韦林或左叶病毒素的贸易和贸易;用于疾病的系统和拟系统治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method of treating a systemic viral disease in a patient has a first step in which the disease is correlated with an increase in Type 1 cytokine activity and a decrease in Type 2 activity. In a further step, a systemic dosage of a drug is identified that is effective to increase the Type 1 activity and decrease the type 2 activity, wherein the drug is Ribavirin or Levovirin™ and in a still further step, the dosage of the drug is administered to the patient via pulmonary delivery. A further method of treating a viral disease has a first step in which the disease is correlated with an infection of dendritic cells, and the dendritic cells are targeted by administering Ribavirin or Levovirin™ via a pulmonary aerosol.
展开▼
